Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β

  1. LiKe Qu1,
  2. Shirley Huang1,
  3. Dionissios Baltzis1,
  4. Ana-Maria Rivas-Estilla1,
  5. Olivier Pluquet1,
  6. Maria Hatzoglou2,
  7. Costas Koumenis3,
  8. Yoichi Taya4,
  9. Akihiko Yoshimura5, and
  10. Antonis E. Koromilas1,6
  1. 1Lady Davis Institute for Medical Research, McGill University, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Québec H3T 1E2, Canada; 2Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA; 3Departments of Radiation Oncology and Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA; 4Radiobiology Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan; 5Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan

Abstract

The tumor suppressor p53, a sensor of multiple forms of cellular stress, is regulated by post-translational mechanisms to induce cell-cycle arrest, senescence, or apoptosis. We demonstrate that endoplasmic reticulum (ER) stress inhibits p53-mediated apoptosis. The mechanism of inhibition involves the increased cytoplasmic localization of p53 due to phosphorylation at serine 315 and serine 376, which is mediated by glycogen synthase kinase-3 β (GSK-3β). ER stress induces GSK-3β binding to p53 in the nucleus and enhances the cytoplasmic localization of the tumor suppressor. Inhibition of apoptosis caused by ER stress requires GSK-3β and does not occur in cells expressing p53 with mutation(s) of serine 315 and/or serine 376 to alanine(s). As a result of the increased cytoplasmic localization, ER stress prevents p53 stabilization and p53-mediated apoptosis upon DNA damage. It is concluded that inactivation of p53 is a protective mechanism utilized by cells to adapt to ER stress.

Keywords

Footnotes

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1165804.

  • Supplemental material is available at http://www.genesdev.org.

  • 6 Corresponding author. E-MAIL antonis.koromilas{at}mcgill.ca; FAX (514) 340-7576.

    • Accepted December 12, 2003.
    • Received October 29, 2003.
| Table of Contents

Life Science Alliance